HC Pharmaceutical selected among Hunan’s top 100 private enterprises - Official website of Kaifu, China

Home>Enterprises

HC Pharmaceutical selected among Hunan’s top 100 private enterprises

Dec 28, 2023 Print

A press conference for the second New Hunan Contribution Award and the 2023 Hunan’s top 100 private enterprises was held on December 25. The Hunan’s top 100 private enterprises for 2023 and its analysis report were released at the conference.

The entry threshold for the top 100 list has reached a new high, with a total operating revenue rising from 2.19 billion yuan in the previous year to 2.775 billion yuan, an increase of 26.71%. Hunan HC Pharmaceutical Group made the list with its outstanding performance and stable development trend for the first time.

HC Pharmaceutical is a pharmaceutical distribution enterprise that serves small and medium-sized chain pharmacies, individual pharmacies and grassroots medical and health institutions.

In recent years, HC Pharmaceutical has rapidly developed a business model that integrates direct supply and exclusive sales. It submitted an IPO application to the Shenzhen Stock Exchange in 2022.

According to the prospectus, HC Pharmaceutical’s main business revenue in 2022 was about 3 billion yuan, with a tax payment of 232 million yuan, and its sales scale continued to grow rapidly.

Since its establishment in 2015, HC Pharmaceutical has been driven by innovation and has established a model of direct supply and exclusive sales with its own brand products as the core through its self-developed B2B e-commerce platform.

This model not only reduces the intermediate links in the traditional medicine circulation field and the purchase cost, but also provides a series of high-quality and affordable medical products for member customers.

In addition, HC Pharmaceutical Group actively explores business innovation based on Internet information technology. Through close cooperation with upstream and downstream industries, the company has achieved significant results in drug research and development, drug acquisition and business system construction, laying a solid foundation for the company’s sustainable development.

Meanwhile, HC Pharmaceutical attaches great importance to talent training and team building. Due to the distinctive characteristics, outstanding highlights and remarkable results in talent work, it was awarded the “future partner” employment and internship base in Kaifu District, Changsha City this year. It was also included in the first batch of “enterprise talent work innovation laboratories” in Jinxia Economic Development Zone.